This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheung, A. M. Y. Articles by Mak, T. W. Search for Related Content PubMed PubMed Citation Articles by Cheung, A. M. Y. Articles by Mak, T. W.

Loss of Brca2 and p53 Synergistically Promotes Genomic Instability and Deregulation of T-cell Apoptosis¹

Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 2M9 [A. M. Y. C., F. J., M-S. T., B. S., J. P. M., J. K., A. W., A. Y-T., A. E., J. S., R. B., R. H., T. W. M.]; Advanced Medical Discovery Institute, Toronto, Ontario, Canada [A. M. Y. C., B. S., J. P. M., A. W., A. Y-T., A. E., R. H., T. W. M.]; Department of Physiology, Faculty of Medicine, National University of Singapore, 117597 Singapore [M. P. H.]; The Sakaguchi Laboratory of Developmental Biology, School of Medicine, Keio University, Tokyo 160-8582, Japan [A. H.]; and Akita University School of Medicine, Department of Biochemistry, Akita 010-8543, Japan [A. S.]

BRCA2 is a breast cancer susceptibility gene of which the product is thought to be involved in monitoring genome integrity and cell cycle progression. Brca2-null mice have a defect in embryonic cellular proliferation and die in utero. Here we report the generation of T-cell lineage-specific Brca2-deficient (tBrca2^-/-) mice using the Cre-loxP system. Mice with a flanked by loxP allele of Brca2 were crossed to transgenic mice bearing Cre recombinase driven by the T cell-specific promoter Lck. Thymic cellularity and distribution of subset populations were normal in tBrca2^-/- mutants. Thymocytes from tBrca2^-/- mice underwent normal apoptosis in response to a variety of stimuli, and activated tBrca2^-/- T cells had normal proliferative capacity. tBrca2^-/- T cells were more likely than wild-type cells to undergo spontaneous apoptosis, but apoptosed normally in response to restimulation or DNA-damaging stress signals. Examination of metaphase spreads of tBrca2^-/- T cells revealed that the chromosomes often exhibited aberrations such as breaks and tri-radial structures. The level of chromosomal abnormalities was enhanced in T cells from tBrca2^-/-; p53^-/- double-mutant mice. However, tBrca2^-/-; p53^-/- T cells did not show the enhanced level of spontaneous apoptosis demonstrated by tBrca2^-/- T cells, a difference that likely accounts for an increase in cell number and ³[H]thymidine incorporation of double-mutant T cells in culture compared with either single mutant. Despite this increased T-cell number, the onset of T-cell lymphomas was only marginally accelerated in tBrca2^-/-; p53^-/- mice compared with p53^-/- mice. Our results support a role for Brca2 in repairing spontaneous DNA lesions, and suggest that loss of Brca2 enhances the susceptibility of mouse T-lineage cells to chromosomal aberrations and deregulation of apoptosis in the absence of p53.

This article has been cited by other articles:

				T. Hay, J. R. Matthews, L. Pietzka, A. Lau, A. Cranston, A. O.H. Nygren, A. Douglas-Jones, G. C.M. Smith, N. M.B. Martin, M. O'Connor, et al. Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53-Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with Carboplatin Cancer Res., May 1, 2009; 69(9): 3850 - 3855. [Abstract] [Full Text] [PDF]

				M. Shen, Q. Lan, L. Zhang, S. Chanock, G. Li, R. Vermeulen, S. M. Rappaport, W. Guo, R. B. Hayes, M. Linet, et al. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity Carcinogenesis, October 1, 2006; 27(10): 2083 - 2089. [Abstract] [Full Text] [PDF]

				J. C. Morales, S. Franco, M. M. Murphy, C. H. Bassing, K. D. Mills, M. M. Adams, N. C. Walsh, J. P. Manis, G. Z. Rassidakis, F. W. Alt, et al. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis PNAS, February 28, 2006; 103(9): 3310 - 3315. [Abstract] [Full Text] [PDF]

				K. A. McAllister, C. D. Houle, J. Malphurs, T. Ward, N. K. Collins, W. Gersch, L. Wharey, J. C. Seely, L. Betz, L. M. Bennett, et al. Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation Toxicol Pathol, February 1, 2006; 34(2): 187 - 198. [Abstract] [Full Text] [PDF]

				A. M. Y. Cheung, A. Elia, M.-S. Tsao, S. Done, K.-U. Wagner, L. Hennighausen, R. Hakem, and T. W. Mak Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation in p53+/- Mutant Mice Cancer Res., March 15, 2004; 64(6): 1959 - 1965. [Abstract] [Full Text] [PDF]

				C. I. Morin and J. Huot Recent Advances in Stress Signaling in Cancer Cancer Res., March 1, 2004; 64(5): 1893 - 1898. [Abstract] [Full Text] [PDF]

				J. M. Ward and D. E. Devor-Henneman Mouse Models of Human Familial Cancer Syndromes Toxicol Pathol, January 1, 2004; 32(1_suppl): 90 - 98. [Abstract] [PDF]